Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renastart Formula Supplementation in Children With AKI
NCT06218212Completed
- Sponsor
- Ain Shams University
- Start
- Feb 2022
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
Randomised, open-label trial in acute kidney injury (AKI) and chronic kidney disease (CKD) (2 arms), sponsored by Ain Shams University. Primary endpoint: Effectiveness and tolerability of Renastart formula to correct and maintain normal serum levels of electrolytes at 3 months. Started Feb 2022; status: completed.
02
Conditions
acute kidney injury (AKI)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT06218212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06218212.